drugset / Trial / NCT05541003

Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome

NCT05541003 ↗

Phase 2 Completed 12 enrolled Rutgers, The State University of New Jersey
NaSingle-groupOpen-labelTreatment

Summary

This study aims to use a high-fiber supplementation, an intervention known to create shifts in the gut microbiota towards a healthier structure, to explore the relationship between gut microbiota, appetite control and feeding behavior in PWS patients.

Timeline

Start
2023-01-06
Primary completion
2023-05-29
Completion
2023-05-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject NBT-NM108 Other / unclassified 24 g Oral